SK285286B6 - Peptidy s antineoplastickým účinkom, ich prípravaa použitie - Google Patents

Peptidy s antineoplastickým účinkom, ich prípravaa použitie Download PDF

Info

Publication number
SK285286B6
SK285286B6 SK767-98A SK76798A SK285286B6 SK 285286 B6 SK285286 B6 SK 285286B6 SK 76798 A SK76798 A SK 76798A SK 285286 B6 SK285286 B6 SK 285286B6
Authority
SK
Slovakia
Prior art keywords
nhch
nhc
pro
xab pro
xaa
Prior art date
Application number
SK767-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK76798A3 (en
Inventor
Wilhelm Amberg
Teresa Barlozzari
Harald Bernard
Ernst Buschmann
Andreas Haupt
Hans-Guenther Hege
Bernd Janssen
Andreas Kling
Helmut Lietz
Kurt Ritter
Martina Ullrich
J�Rgen Weymann
Thomas Zierke
Original Assignee
Abbott Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co. Kg filed Critical Abbott Gmbh & Co. Kg
Publication of SK76798A3 publication Critical patent/SK76798A3/sk
Publication of SK285286B6 publication Critical patent/SK285286B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/10—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using coupling agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK767-98A 1995-12-15 1996-12-11 Peptidy s antineoplastickým účinkom, ich prípravaa použitie SK285286B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57342295A 1995-12-15 1995-12-15
PCT/EP1996/005518 WO1997022621A2 (fr) 1995-12-15 1996-12-11 Peptides neoplasiques

Publications (2)

Publication Number Publication Date
SK76798A3 SK76798A3 (en) 1999-02-11
SK285286B6 true SK285286B6 (sk) 2006-10-05

Family

ID=24291935

Family Applications (1)

Application Number Title Priority Date Filing Date
SK767-98A SK285286B6 (sk) 1995-12-15 1996-12-11 Peptidy s antineoplastickým účinkom, ich prípravaa použitie

Country Status (30)

Country Link
EP (2) EP1593686B1 (fr)
JP (1) JP3939354B2 (fr)
KR (1) KR100463739B1 (fr)
CN (1) CN1127514C (fr)
AR (1) AR004382A1 (fr)
AT (2) ATE471944T1 (fr)
AU (2) AU731458B2 (fr)
BG (1) BG64563B1 (fr)
BR (1) BR9611987A (fr)
CA (1) CA2237721C (fr)
CO (1) CO4750840A1 (fr)
CZ (1) CZ296908B6 (fr)
DE (2) DE69633457T2 (fr)
DK (1) DK0866800T3 (fr)
ES (1) ES2229287T3 (fr)
HR (1) HRP960585A2 (fr)
HU (1) HU228275B1 (fr)
IL (2) IL124342A (fr)
MX (1) MX9803953A (fr)
MY (1) MY114327A (fr)
NO (1) NO319273B1 (fr)
NZ (1) NZ324691A (fr)
PL (1) PL186721B1 (fr)
PT (1) PT866800E (fr)
RU (1) RU2182911C2 (fr)
SK (1) SK285286B6 (fr)
TR (1) TR199801102T2 (fr)
TW (1) TW474946B (fr)
WO (1) WO1997022621A2 (fr)
ZA (1) ZA9610510B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143721A (en) * 1997-07-18 2000-11-07 Basf Aktiengesellschaft Dolastatin 15 derivatives
US5985837A (en) * 1998-07-08 1999-11-16 Basf Aktiengesellschaft Dolastatin 15 derivatives
WO2000051998A1 (fr) 1999-03-02 2000-09-08 Boehringer Ingelheim Pharmaceuticals, Inc. Composes utiles en tant qu'inhibiteurs reversibles de la cathepsine s
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879276A (en) * 1983-12-19 1989-11-07 Uniroyal Chemical Ltd./Uniroyal Chemical Ltee Method for reducing serum uric acid levels
US4816444A (en) * 1987-07-10 1989-03-28 Arizona Board Of Regents, Arizona State University Cell growth inhibitory substance
HUT71398A (en) * 1992-05-20 1995-11-28 Basf Ag Derivatives of dolastatin
US5831002A (en) * 1992-05-20 1998-11-03 Basf Aktiengesellschaft Antitumor peptides
DE69329425T2 (de) * 1992-12-16 2001-01-18 Basf Ag Dolastatin analog
DE4415998A1 (de) * 1994-05-06 1995-11-09 Basf Ag Neue Tetrapeptide, ihre Herstellung Verwendung
DE4415997A1 (de) * 1994-05-06 1995-11-09 Basf Ag Neuer peptidischer Wirkstoff und dessen Herstellung
US5807984A (en) * 1995-11-09 1998-09-15 Basf Aktienegesellschaft Oligopeptides, the preparation and use thereof

Also Published As

Publication number Publication date
SK76798A3 (en) 1999-02-11
AR004382A1 (es) 1998-11-04
WO1997022621A2 (fr) 1997-06-26
TW474946B (en) 2002-02-01
ATE277076T1 (de) 2004-10-15
DE69638206D1 (de) 2010-08-05
IL124342A (en) 2005-06-19
CA2237721C (fr) 2008-01-29
NO319273B1 (no) 2005-07-11
KR20000064400A (ko) 2000-11-06
CN1204342A (zh) 1999-01-06
NO982711D0 (no) 1998-06-12
AU731458B2 (en) 2001-03-29
EP0866800A2 (fr) 1998-09-30
NZ324691A (en) 1999-11-29
PT866800E (pt) 2005-01-31
KR100463739B1 (ko) 2005-02-28
ZA9610510B (en) 1998-06-15
IL124342A0 (en) 1998-12-06
CZ184698A3 (cs) 1998-09-16
BG102479A (en) 1999-06-30
BG64563B1 (bg) 2005-07-29
CZ296908B6 (cs) 2006-07-12
AU1192597A (en) 1997-07-14
MX9803953A (es) 1998-09-30
EP0866800B1 (fr) 2004-09-22
HU228275B1 (en) 2013-02-28
NO982711L (no) 1998-06-12
MY114327A (en) 2002-09-30
JP2000502092A (ja) 2000-02-22
DK0866800T3 (da) 2005-01-17
ATE471944T1 (de) 2010-07-15
ES2229287T3 (es) 2005-04-16
TR199801102T2 (xx) 1998-12-21
PL186721B1 (pl) 2004-02-27
PL327175A1 (en) 1998-11-23
HUP0000172A3 (en) 2000-09-28
WO1997022621A3 (fr) 1998-02-26
JP3939354B2 (ja) 2007-07-04
DE69633457T2 (de) 2005-09-22
DE69633457D1 (de) 2004-10-28
EP1593686B1 (fr) 2010-06-23
AU2004220772B2 (en) 2008-06-12
BR9611987A (pt) 1999-02-17
CN1127514C (zh) 2003-11-12
CO4750840A1 (es) 1999-03-31
HRP960585A2 (en) 1998-02-28
AU2004220772A1 (en) 2004-11-11
RU2182911C2 (ru) 2002-05-27
CA2237721A1 (fr) 1997-06-26
HUP0000172A2 (en) 2000-07-28
IL166853A (en) 2013-03-24
EP1593686A1 (fr) 2005-11-09

Similar Documents

Publication Publication Date Title
AU679479B2 (en) Dolostatin analog
AU725164B2 (en) Novel dolastatin derivatives, their preparation and use
EP0642530A1 (fr) Derives de dolastatine
IL166853A (en) Antineoplastic peptides, their preparation and various uses thereof
US8440626B2 (en) Antineoplastic peptides
AU775090B2 (en) Antineoplastic peptides
SK165497A3 (en) Peptides, preparation method thereof and pharmaceutical composition containing the same

Legal Events

Date Code Title Description
PC4A Assignment and transfer of rights

Owner name: ABBVIE DEUTSCHLAND GMBH & CO. KG, WIESBADEN, DE

Free format text: FORMER OWNER: ABBOTT GMBH & CO. KG, WIESBADEN, DE

Effective date: 20141020

MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20141211